Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Clinica Baviera ( (ES:CBAV) ) has issued an update.
Aier Eye International (Europe), S.L.U. and Vito Gestión Patrimonial, S.L. are exploring the sale of up to 8% of Clínica Baviera’s share capital through an accelerated bookbuilt offering, targeting qualified investors. Alantra Equities is coordinating the operation, which will not provide proceeds to the company, and has agreements in place to restrict further share sales by the sellers for a specified period post-operation.
More about Clinica Baviera
YTD Price Performance: 11.32%
Average Trading Volume: 14
Technical Sentiment Signal: Strong Sell
Current Market Cap: €580.4M
For a thorough assessment of CBAV stock, go to TipRanks’ Stock Analysis page.